FDA Inspection 1020395 — Gulf Coast Regional Blood Center at Pearland
The FDA completed an inspection of Gulf Coast Regional Blood Center at Pearland on July 27, 2017 in Pearland, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 27, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Pearland, TX (United States)